Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Assets: 2017-2025

Historic Return on Assets for Akebia Therapeutics (AKBA) over the last 8 years, with Sep 2025 value amounting to -0.04%.

  • Akebia Therapeutics' Return on Assets rose 17.00% to -0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.30% for FY2024, which is 13.00% down from last year.
  • As of Q3 2025, Akebia Therapeutics' Return on Assets stood at -0.04%, which was up 59.72% from -0.11% recorded in Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Return on Assets ranged from a high of -0.04% in Q3 2025 and a low of -0.62% during Q1 2021.
  • In the last 3 years, Akebia Therapeutics' Return on Assets had a median value of -0.18% in 2023 and averaged -0.20%.
  • Per our database at Business Quant, Akebia Therapeutics' Return on Assets declined by 28bps in 2021 and then spiked by 34bps in 2023.
  • Over the past 5 years, Akebia Therapeutics' Return on Assets (Quarterly) stood at -0.50% in 2021, then grew by 26bps to -0.24% in 2022, then increased by 2bps to -0.22% in 2023, then fell by 11bps to -0.32% in 2024, then increased by 17bps to -0.04% in 2025.
  • Its last three reported values are -0.04% in Q3 2025, -0.11% for Q2 2025, and -0.17% during Q1 2025.